BioCentury
ARTICLE | Clinical News

SVT-40776: Completed Phase II enrollment

October 15, 2007 7:00 AM UTC

The company completed enrollment of 332 patients in a double-blind, dose-finding, international Phase II trial to compare 3 doses of SVT-40776 given once daily vs. 4 mg tolterodine given once daily or...